AJGP
HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Geriatr Psychiatry 5:15-25, February 1997
© 1997 American Association for Geriatric Psychiatry
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a Colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kumar, A.
Right arrow Articles by Gottlieb, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kumar, A.
Right arrow Articles by Gottlieb, G.

Regular Article

Quantitative Anatomic Measures and Comorbid Medical Illness in Late-Life Major Depression

Anand Kumar, M.D., David Miller, M.D., Douglas Ewbank, Ph.D., David Yousem, M.D., Andy Newberg, M.D., Steve Samuels, M.D., Patricia Cowell, Ph.D., and Gary Gottlieb, M.D., M.B.A.

The authors examined the individual and relative roles of atrophy, comorbid medical illness, and cerebrovascular risk factors in the pathogenesis of late-life major depressive disorder (MDD). They used magnetic resonance imaging techniques to study 28 subjects with late-life MDD, 29 healthy control subjects, and 34 subjects with probable dementia of the Alzheimer type (DAT). Depressed subjects showed increases in cerebrospinal fluid volumes comparable to the DAT group but significantly different from control subjects. High-intensity signals, but not measures of atrophy correlated significantly with cerebrovascular risk factor scores. A logistic regression revealed that both brain atrophy and medical illness are associated with an increased risk of developing MDD. Data suggest that both atrophy and comorbid medical illness increase the likelihood of developing MDD in late life.




This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
L L Herrmann, M Le Masurier, and K P Ebmeier
White matter hyperintensities in late life depression: a systematic review
J. Neurol. Neurosurg. Psychiatry, June 1, 2008; 79(6): 619 - 624.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
J. M. Lyness, A. Niculescu, X. Tu, C. F. Reynolds III, and E. D. Caine
The Relationship of Medical Comorbidity and Depression in Older, Primary Care Patients
Psychosomatics, October 1, 2006; 47(5): 435 - 439.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
D. V. Iosifescu, N. Clementi-Craven, R. Fraguas, G. I. Papakostas, T. Petersen, J. E. Alpert, A. A. Nierenberg, and M. Fava
Cardiovascular Risk Factors May Moderate Pharmacological Treatment Effects in Major Depressive Disorder
Psychosom Med, September 1, 2005; 67(5): 703 - 706.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
M. D. Miller, E. J. Lenze, M. A. Dew, E. Whyte, E. Weber, A. E. Begley, and C. F. Reynolds III
Effect of Cerebrovascular Risk Factors on Depression Treatment Outcome in Later Life
Am J Geriatr Psychiatry, October 1, 2002; 10(5): 592 - 598.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
H. Lavretsky, I. M. Lesser, M. Wohl, B. L. Miller, C. M. Mehringer, and H. V. Vinters
Apolipoprotein-E and White-Matter Hyperintensities in Late-Life Depression
Am J Geriatr Psychiatry, August 1, 2000; 8(3): 257 - 261.
[Abstract] [Full Text]


Home page
Am. J. PsychiatryHome page
C. C. Meltzer, J. C. Price, C. A. Mathis, P. J. Greer, M. N. Cantwell, P. R. Houck, B. H. Mulsant, D. Ben-Eliezer, B. Lopresti, S. T. DeKosky, et al.
PET Imaging of Serotonin Type 2A Receptors in Late-Life Neuropsychiatric Disorders
Am J Psychiatry, December 1, 1999; 156(12): 1871 - 1878.
[Abstract] [Full Text]


Home page
AJGPHome page
H. Lavretsky, I. M. Lesser, M. Wohl, B. L. Miller, and C. M. Mehringer
Clinical and Neuroradiologic Features Associated With Chronicity in Late-Life Depression
Am J Geriatr Psychiatry, November 1, 1999; 7(4): 309 - 316.
[Abstract] [Full Text]


Home page
Am. J. PsychiatryHome page
E. Lenze, D. Cross, D. McKeel, R. J. Neuman, and Y. I. Sheline
White Matter Hyperintensities and Gray Matter Lesions in Physically Healthy Depressed Subjects
Am J Psychiatry, October 1, 1999; 156(10): 1602 - 1607.
[Abstract] [Full Text]


Home page
AJGPHome page
J. M. Lyness, E. D. Caine, D. A. King, Y. Conwell, C. Cox, and P. R. Duberstein
Cerebrovascular Risk Factors and Depression in Older Primary Care Patients: Testing a Vascular Brain Disease Model of Depression
Am J Geriatr Psychiatry, August 1, 1999; 7(3): 252 - 258.
[Abstract] [Full Text]


Home page
AJGPHome page
H. Lavretsky, I. M. Lesser, M. Wohl, and B. L. Miller
Relationship of Age, Age at Onset, and Sex to Depression in Older Adults
Am J Geriatr Psychiatry, August 1, 1998; 6(3): 248 - 256.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Kumar, Z. Jin, W. Bilker, J. Udupa, and G. Gottlieb
Late-onset minor and major depression: early evidence for common neuroanatomical substrates detected by using MRI
PNAS, June 23, 1998; 95(13): 7654 - 7658.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
J. M. Lyness, E. D. Caine, C. Cox, D. A. King, Y. Conwell, and T. Olivares
Cerebrovascular Risk Factors and Later-Life Major Depression: Testing a Small-Vessel Brain Disease Model
Am J Geriatr Psychiatry, February 1, 1998; 6(1): 5 - 13.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
Copyright © 1997 American Association for Geriatric Psychiatry